AptarGroup (ATR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
Annual meeting scheduled for May 6, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 5, 2026, or May 3, 2026, for plan shares.
Voting matters and shareholder proposals
Election of four directors: George L. Fotiades, Candace Matthews, B. Craig Owens, and Julie Xing, all recommended by the board.
Advisory vote on executive compensation (say-on-pay) is included.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
Proxies may vote on other business as may properly come before the meeting.
Board of directors and corporate governance
Board recommends all director nominees for election at the annual meeting.
Partial view of Summaries dataset, powered by Quartr API
Latest events from AptarGroup
- Proxy covers director elections, pay, auditor ratification, and strong ESG and governance focus.ATR
Proxy filing27 Mar 2026 - Pharma-led innovation, sustainability, and disciplined capital drive robust 2025 results and outlook.ATR
47th Annual Raymond James Institutional Investor Conference6 Mar 2026 - 2025 growth led by pharma and innovation, with margin expansion and global operational strength.ATR
Bank of America 2026 Global Agriculture and Materials Conference2 Mar 2026 - Q4 2025 sales up 14% but net income down 26%; $486M returned to shareholders.ATR
Q4 20256 Feb 2026 - Profitable growth driven by innovation, efficiency, and strong shareholder returns.ATR
Investor Day 20253 Feb 2026 - Q2 adjusted EPS up 12% to $1.37, driven by Pharma growth and margin gains.ATR
Q2 20242 Feb 2026 - Q3 net income up 19% to $100M; Pharma and Closures drive growth, Beauty faces headwinds.ATR
Q3 202418 Jan 2026 - Pharma innovation, injectables, and digital health drive growth with balanced capital allocation.ATR
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Pharma leads growth with innovation, sustainability, and digital health, supporting raised targets.ATR
43rd Annual J.P. Morgan Healthcare Conference10 Jan 2026